Device Payments Mostly Steady In Medicare Inpatient Proposal
This article was originally published in The Gray Sheet
Executive Summary
Hospitals would see, on average, a small reduction in Medicare reimbursement for inpatient services next year, based on CMS' fiscal 2012 payment proposal, but it is not expected to have a significant impact on overall device pricing or adoption.
You may also be interested in...
St. Jude Announces Key Approvals On Top Of Q1 Results
St. Jude Medical last week announced two important regulatory approvals: a CE mark in Europe for its MRI-friendly pacemaker and an FDA PMA approval for its anticipated stented pericardial tissue heart valve device.
ACC Meeting In Brief
More on MitraClip
St. Jude: CardioMEMS’ Heart Failure Data Reflects Major Opportunity
With the publication of the CHAMPION clinical trial results, CardioMEMS and its suitor St. Jude Medical took another step toward leading the pack in what they say is a multi-billion dollar market opportunity in hemodynamic heart failure monitoring.